Literature DB >> 9451440

Stalling of human DNA (cytosine-5) methyltransferase at single-strand conformers from a site of dynamic mutation.

M R Kho1, D J Baker, A Laayoun, S S Smith.   

Abstract

Single-strand conformers (SSCs) from the C-rich strand of the triplet repeat at the FMR-1 locus are rapidly and selectively methylated by the human DNA (cytosine-5) methyltransferase. The apparent affinity of the enzyme for the FMR-1 SSC is about tenfold higher than it is for a control Watson-Crick paired duplex. The de novo methylation rate for the SSC is over 150-fold higher than the de novo rate for the control duplex. Methylation of what is generally called a hemi-methylated duplex occurs with a rate enhancement of over 100-fold, while methylation of what can be viewed as a hemi-methylated FMR-1 SSC is actually slower than the de novo rate. The pronounced inhibition of the methyltransferase by the methylated SSC suggests that the enzyme has a higher affinity for the methylated product of its reaction with the SSC than it has for the unmethylated SSC substrate. Gel retardation studies show that the methyltransferase binds selectively to SSCs from the C-rich strand of the FMR-1 triplet repeat. This suggests a two-step stalling process in which the human methyltransferase first selectively methlyates and subsequently stalls at the C-rich strand SSC. Stalling may reflect the inability of the enzyme to release a DNA product that is fixed in a conformation resembling its transition state by the unusual structure of the substrate. In particular, the data suggest that DNA methyltransferase may physically participate in biological processes that lead to dynamic mutation at FMR-1. In general, the data raise the possibility that a two-step stalling process occurs at secondary structures associated with chromosome instability, chromosome remodelling, viral replication or viral integration and may account for the local hypermethylation and global hypomethylation associated with viral and non-viral tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451440     DOI: 10.1006/jmbi.1997.1430

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

Review 1.  Human non-CG methylation: are human stem cells plant-like?

Authors:  Olga V Dyachenko; Tara V Schevchuk; Leo Kretzner; Yaroslav I Buryanov; Steven S Smith
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

2.  Towards understanding the epigenetics of transcription by chromatin structure and the nuclear matrix.

Authors:  Rui Pires Martins; Stephen A Krawetz
Journal:  Gene Ther Mol Biol       Date:  2005

3.  Analysis of hypermethylation in the RPS element suggests a signal function for short inverted repeats in de novo methylation.

Authors:  Andreas Müller; Mozart Marins; Yasuko Kamisugi; Peter Meyer
Journal:  Plant Mol Biol       Date:  2002-03       Impact factor: 4.076

4.  Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors.

Authors:  Tien-Yuan Wu; Tin Oo Khor; Zheng-Yuan Su; Constance Lay-Lay Saw; Limin Shu; Ka-Lung Cheung; Ying Huang; Siwang Yu; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2013-05-09       Impact factor: 4.009

5.  Hybrid mouse-prokaryotic DNA (cytosine-5) methyltransferases retain the specificity of the parental C-terminal domain.

Authors:  S Pradhan; R J Roberts
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

6.  Secondary structure at a hot spot for DNA methylation in DNA from human breast cancers.

Authors:  Jarrod Clark; Steven S Smith
Journal:  Cancer Genomics Proteomics       Date:  2008 Sep-Oct       Impact factor: 4.069

7.  Transgene-induced CCWGG methylation does not alter CG methylation patterning in human kidney cells.

Authors:  Taras Shevchuk; Leo Kretzner; Kristofer Munson; John Axume; Jarrod Clark; Olga V Dyachenko; Marie Caudill; Yaroslav Buryanov; Steven S Smith
Journal:  Nucleic Acids Res       Date:  2005-10-24       Impact factor: 16.971

8.  2'-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2'-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites.

Authors:  Katarzyna Lamparska; Jarrod Clark; Gail Babilonia; Victoria Bedell; Wesley Yip; Steven S Smith
Journal:  Nucleic Acids Res       Date:  2012-07-31       Impact factor: 16.971

9.  Interactions within the mammalian DNA methyltransferase family.

Authors:  Jean B Margot; Ann E Ehrenhofer-Murray; Heinrich Leonhardt
Journal:  BMC Mol Biol       Date:  2003-05-30       Impact factor: 2.946

10.  Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers.

Authors:  Koji Tsumagari; Lixin Qi; Kesmic Jackson; Chunbo Shao; Michelle Lacey; Janet Sowden; Rabi Tawil; Vettaikorumakankav Vedanarayanan; Melanie Ehrlich
Journal:  Nucleic Acids Res       Date:  2008-02-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.